The Latest Cardiac and Vascular News
March 8, 2021, filing to raise up to $75 million. Maximum of 1,500,000 shares of Series B preferred stock offered at price of $50 per share. Healthtech Solutions, Inc. is organized to pursue innovation in the field of medical technology. NEW YORK, March 17, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Healthtech […]
New subsidiary will further the Company’s research into treating COVID-related heart muscle injury. A patent has been filed for a therapy to ameliorate and potentially repair myocardial damage. NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Healthtech Solutions, Inc. (OTC: HLTT) (the “Company”), parent company of Medi-Scan, Inc., today […]
